Kiniksa Pharmaceuticals International, plc (KNSA)

SEC filing

Kiniksa Pharmaceuticals International, plc

KNSA · CIK 1730430

4 · Sep 3, 2026 · Director, CHAIRMAN & CEO Patel Sanj K exercised options for 62.64K shares; was granted 150.20K shares; reported 15.14K Class A Ordinary Share

Director, CHAIRMAN & CEO Patel Sanj K exercised options for 62.64K shares; was granted 150.20K shares; reported 15.14K Class A Ordinary Share

Filed: Sep 3, 2026
Period: Sep 1, 2026
Accession: 0001532218-26-000016
Filer: Kiniksa Pharmaceuticals International, plc

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09032026_080911.xml

xslF345X06/form4-09032026_080911.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09032026_080911.xml
Open SEC.gov